Shifting the Paradigm: Early Recognition and Intervention in Alzheimer’s Disease- Describe the clinical and emotional impact on patient well-being resulting from inaccurate and delayed diagnosis of Alzheimer’s disease.
Integrate guidelines and evidence in applying cognitive assessment tools, imaging, and biomarkers to provide early and accurate clinical diagnosis of Alzheimer’s disease.
Summarize model-based pathophysiologic mechanisms of Alzheimer’s disease and implications for evaluation of emerging targeted therapies.
Outline emerging clinical trial data on potential therapies with anti-beta-amyloid agents for the treatment of early Alzheimer’s disease.
1.5 Free CME for Nurses
Expires 12/9/15
Supported by educational grants from Lilly USA, LLC and Novartis